📰 Successful Completion News
Successful Completion News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Successful Completion. Real-time updates on events, politics, business and more.
April 23, 2024
Successful Completion of African Peer Review Mechanisms (APRM) Second Continental Training on South-South and Triangular Cooperation
February 21, 2024
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. EROERO ("Ero" or the "Company") is pleased to announce its 2023 production…
February 16, 2024
SolGold PLC Announces Completion of New Cascabel Pre-Feasibility Study ...
January 16, 2024
Saxon Capital Group, Inc announced the successful culmination of its four-month validation using Energy Glass Solar™ Electrical Producing Panels to power greenhouses passively for the production of...
January 16, 2024
The 5000 sq ft greenhouse in Almeria, Spain, was powered 100% off grid had less than a 5% coverage of Energy Glass Solar™ Panels
January 2, 2024
Yunneng Wind Power Co., Ltd. (Yunneng), the company responsible for the construction and operation of the 640 MW Yunlin offshore wind farm project in Taiwan
November 2, 2023
Intrepid Potash Inc. today announced the successful completion of the Eddy Shaft Brine Extraction Project at its HB solar solution mine in Carlsbad, New Mexico after an eight-month permitting process. The Project provides access to a high-grade brine... - Veroeffentlicht am 02.11.2023
October 19, 2023
New compound added to Basilea’s clinical pipeline; upon successful completion of preclinical profiling, start of phase 2 study planned for H1 2025Upfront payments of USD 2 million Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, October 19, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an as...
October 3, 2023
Successful Completion of 2023 Field Program, Positioning theDonlin Gold Project for the Next Phase of Development Increased Cash and Term Deposits to $130...
September 18, 2023
Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder. The transaction is subject to various terms and conditions, including